Vitamin D: A Ray of Hope in Combating COVID-19‎

Main Article Content

Abdullah Muhammad Sohail
Muhammad Babar Khawar
Ali Afzal
Muhammad Idnan
Sjawal Arshad
Ume Habiba
Syeda Esha Hamid
Sara Shahzaman
Nayab Shahid
Muhammad Ahsan Ashraf
Momna Ramzan


COVID-19, which is caused by the SARS-CoV-2 virus, is the current global pandemic. As it spreads at an exponential and precipitous rate, it causes significant organ damage, which can potentially lead to death. Although there appears to be no specific cure or resistance to this outbreak, the use and administration of Vitamin D (VD) supplements is still a viable option, as evidenced by numerous clinical trials, studies, and observations. The results of the previous investigation have revealed that people with COVID-19 had reduced levels of VD, especially those with severe and critical diseases. The arrangement of receptors such as the angiotensin-converting enzyme (ACE-II) is altered by VD. As a result, it plays an important role in immune system responses to cytokine storms and interleukins. This review aims to uncover and explain how VD might help in combating COVID-19 and possibly hold the key to minimizing its hazard in the light of currently available therapeutic strategies. Finally, we compare and contrast other researcher’s approaches to VD and COVID-19.

Article Details

How to Cite
Sohail, A. M., Khawar, M. B., Afzal, A., Idnan, M., Arshad, S., Habiba, U., Hamid, S. E., Shahzaman, S., Shahid, N., Ashraf, M. A., & Ramzan, M. (2023). Vitamin D: A Ray of Hope in Combating COVID-19‎. Albus Scientia, 2023(1), 1–7.
Review Articles


Ali, N. (2020). Role of vitamin D in preventing of COVID-19 infection, progression, and severity. Journal of Infection and Public Health, 13(10), 1373–1380. DOI:

Alinia-Ahandani, E., & Sheydaei, M. (2020). Overview of the Introduction to the New Coronavirus (Covid19): A Review. Journal of Medical and Biological Science Research, 6(2), 14–20. DOI:

Amaan, H. N., Khawar, M. B., Abbasi, M. H., & Sheikh, N. (2020). Risk assessment in Pakistani health workers during COVID-19 pandemic. RADS Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 126-128. DOI:

Bilezikian, J. P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A. M., Gupta, A., Madhavan, M. V, Nair, N., Babalyan, V., Hutchings, N., Napoli, N., Accili, D., Binkley, N., Landry, D. W., & Giustina, A. (2020). Mechanisms in Endocrinology: Vitamin D and COVID-19. European Journal of Endocrinology, 183(5), R133–R147. DOI:

Cereda, E., Bogliolo, L., de Stefano, L., & Caccialanza, R. (2021). A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019. Current Opinion in Clinical Nutrition & Metabolic Care, 24(1). DOI:

Chan-Yeung, M., & Xu, R.-H. (2003). SARS: Epidemiology. Respirology, 8(s1), S9–S14. DOI:

Čulić, S. (2021). Viral Infections, Including Influenza and Corona Virus Disease 2019, and Vitamin D: A Mini-Review. In Ö. Özdemir (Ed.), Vitamin D (p. Ch. 5). IntechOpen. DOI:

Ebadi, M., & Montano-Loza, A. J. (2020). Perspective: improving vitamin D status in the management of COVID-19. European Journal of Clinical Nutrition, 74(6), 856–859. DOI:

Farooq, A., Abbasi, M. H., Khawar, M. B., & Sheikh, N. (2022). A Recent Update on the Role of Nutraceuticals in COVID-19 Infection. Asian Journal of Health Sciences, 8(2), ID41. DOI:

Gerber, A., Welte, T., Ansorge, S., & Bühling, F. (2002). Expression of Cathepsins B and L in Human Lung Epithelial Cells is Regulated by Cytokines. In Cellular Peptidases in Immune Functions and Diseases (Vol. 477, pp. 287–292). Kluwer Academic Publishers. DOI:

Grant, W., Lahore, H., McDonnell, S., Baggerly, C., French, C., Aliano, J., & Bhattoa, H. (2020). Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients, 12(4), 988. DOI:

Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5(7), 811–818. DOI:

Halline, A. G., Davidson, N. O., Skarosi, S. F., Sitrin, M. D., Tietze, C., Alpers, D. H., & Brasitus, T. A. (1994). Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells. Endocrinology, 134(4), 1710–1717. DOI:

Huang, I.-C., Bosch, B. J., Li, F., Li, W., Lee, K. H., Ghiran, S., Vasilieva, N., Dermody, T. S., Harrison, S. C., Dormitzer, P. R., Farzan, M., Rottier, P. J. M., & Choe, H. (2006). SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells. Journal of Biological Chemistry, 281(6), 3198–3203. DOI:

Jones, G., Strugnell, S. A., & DeLuca, H. F. (1998). Current Understanding of the Molecular Actions of Vitamin D. Physiological Reviews, 78(4), 1193–1231. DOI:

Kahn, J. S., & McIntosh, K. (2005). History and Recent Advances in Coronavirus Discovery. Pediatric Infectious Disease Journal, 24(11), S223–S227. DOI:

Kalra, E. K. (2003). Nutraceutical-definition and introduction. AAPS PharmSci, 5(3), 27–28. DOI:

Khare, D., Godbole, N. M., Pawar, S. D., Mohan, V., Pandey, G., Gupta, S., Kumar, D., Dhole, T. N., & Godbole, M. M. (2013). Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. European Journal of Nutrition, 52(4), 1405–1415. DOI:

Khawar, M. B., Abbasi, M. H., Hussain, S., Riaz, M., Rafiq, M., Mehmood, R., Sheikh, N., Amaan, H. N., Fatima, S., Jabeen, F., Ahmad, Z., & Farooq, A. (2021). Psychological impacts of COVID-19 and satisfaction from online classes: disturbance in daily routine and prevalence of depression, stress, and anxiety among students of Pakistan. Heliyon, 7(5), e07030. DOI:

Khawar, M. B., Abbasi, M. H., Sheikh, N., Riaz, M., Rafiq, M., Farooq, A., Ahmad, Z., Fatima, S., & Amaan, H. N. (2022). Second Wave Scenario of COVID-19 in Pakistan and Combating Strategies. Albus Scientia, 2022(1), e220430. DOI:

Kim, I. M., Norris, K. C., & Artaza, J. N. (2016). Vitamin D and Cardiac Differentiation. Vitamins and Hormones, 100, 299–320. DOI:

Laaksi, I., Ruohola, J.-P., Tuohimaa, P., Auvinen, A., Haataja, R., Pihlajamäki, H., & Ylikomi, T. (2007). An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. The American Journal of Clinical Nutrition, 86(3), 714–717. DOI:

Laird, E., Rhodes, J., & Kenny, R. (2020). Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. Irish Medical Journal, 113, 81.

Lei, G.-S., Zhang, C., Cheng, B.-H., & Lee, C.-H. (2017). Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. Antimicrobial Agents and Chemotherapy, 61(10). DOI:

Li, Z., Chen, Y., Yang, B., Song, H., Chen, W., & Zhou, H. (2021). Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID 19) pneumonia during the first chemotherapy cycle: A case report. Experimental and Therapeutic Medicine, 21(4), 392. DOI:

Lips, P. (2006). Vitamin D physiology. Progress in Biophysics and Molecular Biology, 92(1), 4–8. DOI:

Lordan, R., Rando, H. M., & Greene, C. S. (2021). Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment. mSystems, 6(3). DOI:

McCartney, D., & Byrne, D. (2020). Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19. Irish Medical Journal, 113, 58.

McGonagle, D. , O’Donnell, J. S. , Sharif, K. , Emery, P. , & Bridgewood, C. (2020). Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. The Lancet Rheumatology, 2(7), e437–e445. DOI:

Meltzer, D. O., Best, T. J., Zhang, H., Vokes, T., Arora, V., & Solway, J. (2020). Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Network Open, 3(9), e2019722–e2019722. DOI:

Mohan, M., Cherian, J. J., & Sharma, A. (2020). Exploring links between vitamin D deficiency and COVID-19. PLOS Pathogens, 16(9), e1008874. DOI:

Nasri, H., Baradaran, A., Shirzad, H., & Rafieian-Kopaei, M. (2014). New Concepts in Nutraceuticals as Alternative for Pharmaceuticals. In International Journal of Preventive Medicine (Vol. 5, Issue 12).

Rastogi, A., Bhansali, A., Khare, N., Suri, V., Yaddanapudi, N., Sachdeva, N., Puri, G. D., & Malhotra, P. (2022). Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgraduate Medical Journal, 98(1156), 87–90. DOI:

Razdan, K., Singh, K., & Singh, D. (2020). Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation? Medicine in Drug Discovery, 7, 100051. DOI:

Silberstein, M. (2020). Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D. International Immunopharmacology, 88, 106995. DOI:

Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019). Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections. Frontiers in Microbiology, 10. DOI:

Škrovánková, S. (2011). Seaweed Vitamins as Nutraceuticals. Advances in Food and Nutrition Research, 64, 357–369. DOI:

Umar, M., Sastry, K., & Chouchane, A. (2018). Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies. International Journal of Molecular Sciences, 19(6), 1618. DOI:

Vimaleswaran, K. S., Forouhi, N. G., & Khunti, K. (2021). Vitamin D and covid-19. BMJ, n544. DOI:

Wang, L., Ahn, M., & E. Anderson, D. (2021). Bats and Coronaviruses in the Context of COVID-19. China CDC Weekly, 3(7), 153–155. DOI:

Wang, T.-T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., & White, J. H. (2004). Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. The Journal of Immunology, 173(5), 2909–2912. DOI:

Most read articles by the same author(s)